COBRA Hemagglutinin and cGAMP Loaded Ace-DEX Microparticles Provide a Broadly Active and Shelf-Stable Influenza Vaccine Platform
{{output}}
Current FDA-approved influenza vaccines are limited by variable year to year efficacy, low immunogenicity, and poor stability outside of cold-chain storage. Polymeric microparticles can overcome many of these issues to provide an improved influenza vaccine pla... ...
